High‐performance thin layer chromatographic method development and validation for simultaneous estimation of solifenacin succinate and silodosin using quality by design approach and greenness assessment

Author:

Lodha Sandesh1ORCID,Pillai Arya1,Kalyankar Gajanan1,Dedhiya Praful1,Joshi Shrikant1,Shah Shailesh1,Shah Dinesh1

Affiliation:

1. Maliba Pharmacy College Uka Tarsadia University Surat Gujarat India

Abstract

AbstractThe current research developed a high‐performance thin layer chromatographic method based on green analytical chemistry and integrated experimental approaches of analytical quality by design for simultaneous estimation of solifenacin succinate and silodosin. The integration was planned to reduce energy and solvent usage, maximize efficacy, and minimize any negative environmental effects. Taguchi design for screening and optimization a Box–Behnken design was used. The n‐butanol:ethanol:triethylamine (6:4:0.1, v/v/v) mobile phase and ultraviolet detection at 221 nm were used to develop the method. As per International Council for Harmonization Q2(R1) specifications, the method was validated. Rf value for solifenacin succinate and silodosin was found to be 0.29 ± 0.02 and 0.58 ± 0.02 respectively. For solifenacin succinate and silodosin, the linearity was found over the concentration ranges of 500–2500 ng/band and 800–4000 ng/band. For solifenacin succinate, the limits of detection and quantification were found to be 13.00 and 39.34 ng/band, respectively, while for silodosin, they were 33.29 and 100.86 ng/band, respectively. For solifenacin succinate, the method revealed a percent recovery ranging from 98.49% to 99.50%, while for silodosin, it exhibited a range from 98.86% to 99.79%. The tools predicted greenness score to be 63 and 0.78, respectively, indicating the proposed method to be green.

Publisher

Wiley

Subject

Filtration and Separation,Analytical Chemistry

Reference41 articles.

1. NgM BaradhiKM Benign Prostatic Hyperplasia StatPearls https://www.statpearls.com/point-of-care/18212

2. Current treatments for benign prostatic hyperplasia;Miernik A;Dtsch Arztebl Int,2020

3. Pathophysiology of overactive bladder and urge urinary incontinence;Steers WD;Rev Urol,2002

4. Clinical Pharmacokinetics and Pharmacodynamics of Solifenacin

5. https://go.drugbank.com/drugs/DB01591 https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021518s017lbl.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3